Prevena Spine for Use in Spine Surgery
A Prospective, Single-center Study for the Investigation of the Use of Prevena Vacuum-Assisted Closure Devices in Patients Undergoing Spine Surgery
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Contact
Study Contact
- Name: Robert Galiano, MD
- Phone Number: 312-695-6022
- Email: robert.galiano@nm.org
Study Contact Backup
- Name: Tokoya Williams, MD
- Phone Number: 3126955667
- Email: tokoya.williams@northwestern.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients undergoing spinal fusion surgery
- Over 18 years old
Exclusion Criteria:
- Medical or psychiatric condition that may increase the risk with study participation, may complicate patient compliance, or may interfere with the interpretation of study results and, in the judgment of the Investigator, would make the subject inappropriate for entry into this study
- Subjects who are pregnant at the date of surgery (SOC for surgery)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Group 2 (Prevena)
Prospective group of patients receiving spine surgery who will have Prevena applied to incision area.
|
Patients will receive spine surgery
The investigators will utilize the KCI USA, Inc Prevena Plus 125 vacuum-assisted closure device in patients undergoing spine surgery as a method to prevent surgical site infections and wound dehiscence after surgery.
The device has been approved by the FDA under the name "Prevena 125 and Prevena Plus 125 Therapy Units" and regulation number 21CFR 878.4783.
|
|
Placebo Comparator: Group 1 (control)
Prospective control of patients who did not use Prevena following spine surgery.
|
Patients will receive spine surgery
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of Surgical site infections
Time Frame: 1-6 weeks following surgery
|
Determine if infection is present at surgical site or not.
|
1-6 weeks following surgery
|
|
Frequency of Wound dehiscence
Time Frame: 1-6 weeks following surgery
|
Determine if wound reopening (dehiscence) is present at surgical site or not.
|
1-6 weeks following surgery
|
|
Frequency of Seroma
Time Frame: 1-6 weeks following surgery
|
Determine if seromas (collection of fluid under the skin) are present at surgical site or not.
|
1-6 weeks following surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of skin necrosis
Time Frame: 1-6 weeks following surgery
|
Measure the frequency of patients who experience skin necrosis in the incision area
|
1-6 weeks following surgery
|
|
Frequency of readmission
Time Frame: 1-6 weeks following surgery
|
Measure the frequency of patients who are readmitted following surgery due to wound-related complications
|
1-6 weeks following surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- STU00216293
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.